GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Asymchem Laboratories Tianjin Co Ltd (SZSE:002821) » Definitions » Other Net Income (Loss)

Asymchem Laboratories Tianjin Co (SZSE:002821) Other Net Income (Loss) : ¥0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Asymchem Laboratories Tianjin Co Other Net Income (Loss)?

Asymchem Laboratories Tianjin Co's Other Net Income (Loss) for the three months ended in Mar. 2024 was ¥-0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0 Mil.

Asymchem Laboratories Tianjin Co's quarterly Other Net Income (Loss) declined from Sep. 2023 (¥0 Mil) to Dec. 2023 (¥0 Mil) and declined from Dec. 2023 (¥0 Mil) to Mar. 2024 (¥-0 Mil).

Asymchem Laboratories Tianjin Co's annual Other Net Income (Loss) increased from Dec. 2021 (¥0 Mil) to Dec. 2022 (¥0 Mil) but then declined from Dec. 2022 (¥0 Mil) to Dec. 2023 (¥-0 Mil).


Asymchem Laboratories Tianjin Co Other Net Income (Loss) Historical Data

The historical data trend for Asymchem Laboratories Tianjin Co's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Asymchem Laboratories Tianjin Co Other Net Income (Loss) Chart

Asymchem Laboratories Tianjin Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Net Income (Loss)
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Asymchem Laboratories Tianjin Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Net Income (Loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Asymchem Laboratories Tianjin Co Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Asymchem Laboratories Tianjin Co Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Asymchem Laboratories Tianjin Co's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.


Asymchem Laboratories Tianjin Co (SZSE:002821) Business Description

Traded in Other Exchanges
Address
No. 6 Dongting Third Street, Economic and Technological Development Zone, Tianjin, CHN, 300457
Asymchem Laboratories Tianjin Co Ltd is a China-based company, a technology-driven provider of Contract Development Manufacture Organization solutions throughout the drug development and manufacturing process. The Group provides clinical-stage CDMO solutions, commercial-stage CDMO solutions, and emerging services. Its operations relate to contract development and manufacturing which focuses on innovation and commercial application of global pharmaceutical technology.
Executives
Xiao Yi Executives
Xu Xiang Ke Directors, executives
Zhou Yan Executives
Chen Chao Yong Executives
Huang Xiao Lian Executives
Yang Jing Director
Executives

Asymchem Laboratories Tianjin Co (SZSE:002821) Headlines

No Headlines